Approvals/TGA/AROPAX CR paroxetine 12.5mg (as hydrochloride hemihydrate) modified release tablet

Approved

STANDARD

AROPAX CR paroxetine 12.5mg (as hydrochloride hemihydrate) modified release tablet

Aspen Pharmacare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 05bb974901110d24
Product Name: AROPAX CR paroxetine 12.5mg (as hydrochloride hemihydrate) modified release tablet
Artg Id: 101596
Artg Name: AROPAX CR paroxetine 12.5mg (as hydrochloride hemihydrate) modified release tablet blister pack
Sponsor: Aspen Pharmacare Australia Pty Ltd
Company Detail Path: /organization/aspen-pharmacare-australia-pty-ltd
Artg Date: 2004-05-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

05bb974901110d24

Type

Standard